Genotoxic factors associated with the development of receptor-negative breast cancer: potential role of the phenomenon of switching of estrogen effects
Aim: About 30–40% of breast cancers lack steroid receptors (ER and/or PR) at diagnosis that worsen prognosis and limit the usage of hormone therapy. The aim of this paper has been to study the role of DNA-damaging factors as the potential modifiers of the receptor-negative tumors incidence. Material...
Gespeichert in:
| Veröffentlicht in: | Experimental Oncology |
|---|---|
| Datum: | 2006 |
| Hauptverfasser: | Berstein, L.M., Tsyrlina, E.V., Poroshina, T.E., Levina, V.V., Vasilyev, D.A., Kovalenko, I.G., Semiglazov, V.F. |
| Format: | Artikel |
| Sprache: | English |
| Veröffentlicht: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2006
|
| Schlagworte: | |
| Online Zugang: | https://nasplib.isofts.kiev.ua/handle/123456789/134529 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Назва журналу: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Zitieren: | Genotoxic factors associated with the development of receptor-negative breast cancer: potential role of the phenomenon of switching of estrogen effects / L.M. Berstein, E.V. Tsyrlina, T.E. Poroshina, V.V. Levina, D.A. Vasilyev, I.G. Kovalenko, V.F. Semiglazov // Experimental Oncology. — 2006. — Т. 28, № 1. — С. 64-69. — Бібліогр.: 32 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of UkraineÄhnliche Einträge
-
Expression of the estrogen and progesterone receptors as prognostic factor in serous ovarian cancers
von: Buchynska, L.G., et al.
Veröffentlicht: (2009) -
Prognostic role of androgen receptor expression in patients with metastatic triple negative breast cancer
von: Lyalkin, S.A., et al.
Veröffentlicht: (2023) -
Expression of drug resistance proteins in triple-receptor-negative tumors as the basis of individualized therapy of the breast cancer patients
von: Chekhun, V.F., et al.
Veröffentlicht: (2009) -
Cytochrome P450, estrogen metabolites and superoxide radicals in breast cancer initiation and progression
von: A. P. Burlaka, et al.
Veröffentlicht: (2020) -
Clinical significance of estrogen receptor gene ERS1 SNP in cancer patients from families with oncological pathology in pedigrees
von: Paliychuk, O.V, et al.
Veröffentlicht: (2016)